Blood-Brain Barrier Leakage in Patients with Early Alzheimer Disease
Open accessThe DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
Purpose To investigate whether the blood-brain barrier (BBB) leaks blood-circulating substances in patients with early forms of Alzheimer disease (AD), and if so, to examine the extent and pattern of leakage. Materials and Methods This study was approved by the local medical ethical committees of the Maastricht University Medical Center and Leiden University Medical Center, and written informed consent was obtained from all subjects. For this pilot study, 16 patients with early AD and 17 healthy age-matched control subjects underwent dynamic contrast material–enhanced magnetic resonance (MR) imaging sequence with dual time resolution for 25 minutes. The Patlak graphical approach was used to quantify the BBB leakage rate and local blood plasma volume. Subsequent histogram analysis was used to determine the volume fraction of the leaking brain tissue. Differences were assessed with linear regression analysis, adjusted for confounding variables. Results The BBB leakage rate was significantly higher in patients compared with that in control subjects in the total gray matter (P < .05) and cortex (P = .03). Patients had a significantly higher volume fraction of the leaking brain tissue in the gray matter (P = .004), normal-appearing white matter (P < .04), deep gray matter (P = .01), and cortex (P = .004). When all subjects were considered, scores on the Mini-Mental State Examination decreased significantly with increasing leakage in the deep gray matter (P = .007) and cortex (P < .05). Conclusion The results of this study showed global BBB leakage in patients with early AD that is associated with cognitive decline. A compromised BBB may be part of a cascade of pathologic events that eventually lead to cognitive decline and dementia. ©RSNA, 2016 Online supplemental material is available for this article. An earlier incorrect version of this article appeared online. This article was corrected on October 24, 2016.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Recent neuroimaging studies in individuals with mild cognitive impairment (MCI) and early AD reveal BBB breakdown in the hippocampus, including its CA1 and dentate gyrus subfields (421), and several gray and white matter regions (220-222), respectively, before brain atrophy and dementia.”
From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [220]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“BBB leakiness is seen both with normal ageing and AD [124,125].”
From Ageing, Cellular Senescence and Neurodegenerative Disease (2018) · cites this paper as [125]
The cited source says what the claim attributes to it.
In the citing paper
“Indeed, the BBB disruption and increased permeability have been shown to occur in the early phase of the AD pathology (van de Haar et al., 2016).”
From Exploring the Therapeutic Potential of Phytochemicals in Alzheimer’s Disease: Focus on Polyphenols and Monoterpenes (2022) · cites this paper as van de Haar et al., 2016
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
McKhann, G. M., Knopman, D. S., Chertkow, H., Hyman, B. T., Jack, C. R., Kawas, C. H., Klunk, W. E., Koroshetz, W. J., Manly, J. J., Mayeux, R., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.005 · Cited by 18,657
The Clinical Dementia Rating (CDR): Current version and scoring rules
Morris, J. C. (1993) · Neurology · doi:10.1212/wnl.43.11.2412-a · Cited by 9,882
Astrocyte-endothelial interactions at the blood-brain barrier
Abbott, N. J., Rönnbäck, L., & Hansson, E. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1824 · Cited by 5,595
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
Jack, C. R., Knopman, D. S., Jagust, W. J., Shaw, L. M., Aisen, P. S., Weiner, M. W., Petersen, R. C., & Trojanowski, J. Q. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70299-6 · Cited by 4,806
Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteria
Dubois, B., Feldman, H. H., Jacova, C., DeKosky, S. T., Barberger-Gateau, P., Cummings, J., Delacourte, A., Galasko, D., Gauthier, S., Jicha, G., et al. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70178-3 · Cited by 4,411
Graphical Evaluation of Blood-to-Brain Transfer Constants from Multiple-Time Uptake Data
Patlak, C. S., Blasberg, R. G., & Fenstermacher, J. D. (1983) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1983.1 · Cited by 3,567
The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders
Zlokovic, B. V. (2008) · Neuron · doi:10.1016/j.neuron.2008.01.003 · Cited by 3,280
Blood-brain barrier breakdown in the aging human hippocampus
Montagne, A., Barnes, S. R., Sweeney, M. D., Halliday, M. R., Sagare, A. P., Zhao, Z., Toga, A. W., Jacobs, R. E., Liu, C. Y., Amezcua, L., et al. (2015) · Neuron · doi:10.1016/j.neuron.2014.12.032 · Cited by 2,102
Research works printed but not linked: 1
- Butman J, 2006, Proceedings of the Fourteenth Meeting of the International Society for Magnetic Resonance in Medicine, 1535
Cited by
Items 101–200 of 653
Amyloid-β specific regulatory T cells attenuate Alzheimer’s disease pathobiology in APP/PS1 mice
Yeapuri, P., Machhi, J., Lu, Y., Abdelmoaty, M. M., Kadry, R., Patel, M., Bhattarai, S., Lu, E., Namminga, K. L., Olson, K. E., et al. (2023) · Molecular Neurodegeneration · doi:10.1186/s13024-023-00692-7 · Cited by 107
Neurofluid Dynamics and the Glymphatic System: A Neuroimaging Perspective
Taoka, T., & Naganawa, S. (2020) · Korean Journal of Radiology · doi:10.3348/kjr.2020.0042 · Cited by 106
Tau hyperphosphorylation induces oligomeric insulin accumulation and insulin resistance in neurons
Rodriguez-Rodriguez, P., Sandebring-Matton, A., Merino-Serrais, P., Parrado-Fernandez, C., Rabano, A., Winblad, B., Ávila, J., Ferrer, I., & Cedazo-Minguez, A. (2017) · Brain · doi:10.1093/brain/awx256 · Cited by 94
Extra-virgin olive oil for potential prevention of Alzheimer disease
Román, G. C., Jackson, R. E., Reis, J. J., Roman, A., Toledo, J. B., & Toledo, E. (2019) · Revue Neurologique · doi:10.1016/j.neurol.2019.07.017 · Cited by 106
Functional MRI of brain physiology in aging and neurodegenerative diseases
Chen, J. J. (2018) · NeuroImage · doi:10.1016/j.neuroimage.2018.05.050 · Cited by 104
Cerebral Small Vessel Disease (CSVD) – Lessons From the Animal Models
Mustapha, M., Nassir, C. M. N. C. M., Aminuddin, N., Safri, A. A., & Ghazali, M. M. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.01317 · Cited by 103
Neurovascular dysfunction and vascular amyloid accumulation as early events in Alzheimer's disease
Apátiga-Pérez, R., Soto-Rojas, L. O., Campa-Córdoba, B. B., Luna‐Viramontes, N. I., Cuevas, E., Villanueva‐Fierro, I., Ontiveros‐Torres, M. Á., Bravo-Muñoz, M., Flores-Rodríguez, P., Garcés‐Ramírez, L., et al. (2021) · Metabolic Brain Disease · doi:10.1007/s11011-021-00814-4 · Cited by 101
Bulens, P., Couwenberg, A. M., Intven, M., Debucquoy, A., Vandecaveye, V., Cutsem, E. V., D’Hoore, A., Wolthuis, A. M., Mukherjee, P., Gevaert, O., et al. (2019) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2019.07.033 · Cited by 100
Interactions between glial cells and the blood-brain barrier and their role in Alzheimer's disease
Zhao, M., Jiang, X., Zhang, H., Sun, J., Pei, H., Ma, L., Cao, Y., & Li, H. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101483 · Cited by 99
Varatharaj, A., Liljeroth, M., Darekar, A., Larsson, H. B. W., Galea, I., & Cramer, S. P. (2018) · The Journal of Physiology · doi:10.1113/jp276887 · Cited by 98
Rifaai, R. A., Mokhemer, S. A., Saber, E. A., El-Aleem, S. A. A., & El-Tahawy, N. F. G. (2020) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2020.101795 · Cited by 86
From Neurodevelopmental to Neurodegenerative Disorders: The Vascular Continuum
Ouellette, J., & Lacoste, B. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.749026 · Cited by 98
In vivo methods for imaging blood–brain barrier function and dysfunction
Harris, W. J., Asselin, M., Hinz, R., Parkes, L. M., Allan, S. M., Schießl, I., Boutin, H., & Dickie, B. (2022) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-022-05997-1 · Cited by 98
Loeffler, D. A. (2023) · Journal of Alzheimer's Disease Reports · doi:10.3233/adr-230025 · Cited by 79
The gut microbiome and Alzheimer’s disease: Complex and bidirectional interactions
Tarawneh, R. M., & Penhos, E. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104814 · Cited by 97
Chetty, C. A., Bhardwaj, H., Kumar, G. P., Devanand, T., Sekhar, C. S. A., Aktürk, T., Kıyı, İ., Yener, G., Güntekin, B., Joseph, J., et al. (2024) · Alzheimer s Research & Therapy · doi:10.1186/s13195-024-01582-w · Cited by 97
Taoka, T., & Naganawa, S. (2020) · Japanese Journal of Radiology · doi:10.1007/s11604-020-01017-0 · Cited by 95
He, J.-T., Zhao, X., Xu, L., & Mao, C.-Y. (2020) · Journal of Alzheimer’s Disease · doi:10.3233/jad-190764 · Cited by 84
Vázquez-Rosa, E., Shin, M.-K., Dhar, M., Chaubey, K., Cintrón-Pérez, C. J., Tang, X., Liao, X., Miller, E., Koh, Y., Barker, S., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2010430117 · Cited by 88
Taoka, T., Jošt, G., Frenzel, T., Naganawa, S., & Pietsch, H. (2018) · Investigative Radiology · doi:10.1097/rli.0000000000000473 · Cited by 93
Neural stem cell therapy for neurovascular injury in Alzheimer's disease
Boese, A. C., Hamblin, M. H., & Lee, J.-P. (2020) · Experimental Neurology · doi:10.1016/j.expneurol.2019.113112 · Cited by 86
Magnetic Resonance Imaging of Blood–Brain Barrier permeability in Dementia
Chagnot, A., Barnes, S. R., & Montagne, A. (2021) · Neuroscience · doi:10.1016/j.neuroscience.2021.08.003 · Cited by 80
Preininger, M. K., & Kaufer, D. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23116217 · Cited by 92
Wang, Y., Wu, J., Wang, J., He, L., Lai, H., Zhang, T., Wang, X., & Li, W. (2023) · Mitochondrion · doi:10.1016/j.mito.2023.01.007 · Cited by 92
The Blood–Brain Barrier: Composition, Properties, and Roles in Brain Health
Lacoste, B., Prat, A., Andrade, M. F., & Gu, C. (2024) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a041422 · Cited by 94
Ott, B. R., Jones, R. N., Daiello, L. A., de la Monte, S. M., Stopa, E. G., Johanson, C. E., Denby, C., & Grammas, P. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00245 · Cited by 91
Freeze, W. M., Jacobs, H. I. L., de Jong, J. J., Verheggen, I. C. M., Gronenschild, E. H. B. M., Palm, W. M., Hoff, E. I., Wardlaw, J. M., Jansen, J. F. A., Verhey, F. R., et al. (2020) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2019.09.017 · Cited by 87
Self-citationRetinal Vasculopathy in Alzheimer’s Disease
Shi, H., Koronyo, Y., Rentsendorj, A., Fuchs, D.-T. S., Sheyn, J., Black, K. L., Mirzaei, N., & Koronyo‐Hamaoui, M. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.731614 · Cited by 91
Divecha, Y. A., Rampes, S., Tromp, S., Boyanova, S., Fleckney, A. L., Fidanboylu, M., & Thomas, S. A. (2025) · Pharmacological Reviews · doi:10.1016/j.pharmr.2025.100052 · Cited by 92
Brain injury-induced dysfunction of the blood brain barrier as a risk for dementia
Abrahamson, E. E., & Ikonomovic, M. D. (2020) · Experimental Neurology · doi:10.1016/j.expneurol.2020.113257 · Cited by 86
Spampinato, S. F., Merlo, S., Sano, Y., Kanda, T., & Sortino, M. A. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.14068 · Cited by 90
Morofuji, Y., & Nakagawa, S. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666200224112534 · Cited by 90
Nzou, G., Wicks, R. T., VanOstrand, N. R., Mekky, G. A., Seale, S. A., El-Taibany, A. A., Wicks, E. E., Nechtman, C. M., Marrotte, E. J., Makani, V. S., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-66487-8 · Cited by 90
Imaging the role of blood–brain barrier disruption in normal cognitive ageing
Verheggen, I. C. M., de Jong, J. J. A., van Boxtel, M. P. J., Postma, A. A., Jansen, J. F. A., Verhey, F. R. J., & Backes, W. H. (2020) · GeroScience · doi:10.1007/s11357-020-00282-1 · Cited by 81
“Thus, BBB disruption is considered as an early event in the pathological cascade possibly leading to neurodegeneration [15, 38].”
BackgroundMethodSelf-citationRuczaj, A., & Brzoska, M. M. (2022) · Journal of Applied Toxicology · doi:10.1002/jat.4322 · Cited by 91
Microvascular Dysfunction Is Associated With Worse Cognitive Performance: The Maastricht Study
Rensma, S. P., van Sloten, T. T., Houben, A. J. H. M., Köhler, S., van Boxtel, M. P. J., Berendschot, T. T. J. M., Jansen, J. F. A., Verhey, F. R. J., Kroon, A. A., Koster, A., et al. (2019) · Hypertension · doi:10.1161/hypertensionaha.119.13023 · Cited by 88
Self-citationUchida, Y., Kan, H., Sakurai, K., Oishi, K., & Matsukawa, N. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1111448 · Cited by 88
Agarwal, N., Lewis, L. D., Hirschler, L., Rivera‐Rivera, L. A., Naganawa, S., Levendovszky, S. R., Ringstad, G. A., Klarica, M., Wardlaw, J. M., Iadecola, C., et al. (2023) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.28759 · Cited by 88
Melchiorri, D., Merlo, S., Micallef, B., Borg, J.-J., & Dráfi, F. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1196413 · Cited by 70
Ting, K. K., Coleman, P., Kim, H. J., Zhao, Y., Mulangala, J., Cheng, N. C., Li, W., Gunatilake, D., Johnstone, D. M., Loo, L., et al. (2023) · GeroScience · doi:10.1007/s11357-023-00927-x · Cited by 76
Poon, C. T., Shah, K., Lin, C., Tse, R., Kim, K. K., Mooney, S., Aubert, I., Stefanovic, B., & Hynynen, K. (2018) · Scientific Reports · doi:10.1038/s41598-018-32250-3 · Cited by 79
van de Haar, H. J., Jansen, J. F. A., Jeukens, C. R. L. P. N., Burgmans, S., van Buchem, M. A., Muller, M., Hofman, P. A. M., Verhey, F. R. J., van Osch, M. J. P., & Backes, W. H. (2017) · Medical Physics · doi:10.1002/mp.12328 · Cited by 85
Self-citationCerebrovascular plasticity: Processes that lead to changes in the architecture of brain microvessels
Bogorad, M. I., DeStefano, J. G., Linville, R. M., Wong, A. D., & Searson, P. C. (2019) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x19855875 · Cited by 85
Vinje, V., Zapf, B., Ringstad, G., Eide, P. K., Rognes, M. E., & Mardal, K.-A. (2023) · Fluids and Barriers of the CNS · doi:10.1186/s12987-023-00459-8 · Cited by 83
Nakajima, S., Gotoh, M., Fukasawa, K., Murakami-Murofushi, K., & Kunugi, H. (2019) · Brain Research · doi:10.1016/j.brainres.2019.146484 · Cited by 72
Chowdhury, E. A., Noorani, B., Alqahtani, F., Bhalerao, A., Raut, S., Sivandzade, F., & Cucullo, L. (2021) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x20985946 · Cited by 81
Wang, J., Fan, D., Li, H.-Y., He, C.-Y., Shen, Y., Zeng, G., Chen, D., Yi, X., Ma, Y., Yu, J., et al. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00512-w · Cited by 81
Noninvasive Magnetic Resonance Imaging Measures of Glymphatic System Activity
Kamagata, K., Saito, Y., Andica, C., Uchida, W., Takabayashi, K., Yoshida, S., Hagiwara, A., Fujita, S., Nakaya, M., Akashi, T., et al. (2023) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.28977 · Cited by 82
Shih, C.-H., Chen, J., Kuo, L., Cho, K.-H., Hsiao, T.-C., Lin, Z.-W., Lin, Y.-S., Kang, J., Lo, Y., Chuang, K.-J., et al. (2018) · Particle and Fibre Toxicology · doi:10.1186/s12989-018-0281-1 · Cited by 81
Modarres, H. P., Janmaleki, M., Novin, M., Saliba, J., Moussa, F. E. H., Charan, M. R., Seyfoori, A., SadAbadi, H., Vandal, M., Nguyen, M. D., et al. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.01.024 · Cited by 80
Altendorfer, B., Unger, M. S., Poupardin, R., Hoog, A., Asslaber, D., Gratz, I. K., Mrowetz, H., Benedetti, A., de Sousa, D. M. B., Greil, R., et al. (2022) · The Journal of Immunology · doi:10.4049/jimmunol.2100737 · Cited by 80
Storck, S. E., & Pietrzik, C. U. (2017) · Pharmaceutical Research · doi:10.1007/s11095-017-2267-3 · Cited by 79
Imaging and Molecular Mechanisms of Alzheimer’s Disease: A Review
Femminella, G. D., Thayanandan, T., Calsolaro, V., Komici, K., Rengo, G., Corbi, G., & Ferrara, N. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19123702 · Cited by 79
“To investigate if the leakage could contribute to AD, a pilot study with a dynamic contrast-enhanced MRI was conducted on a population of MCI due to AD and early AD by Maastricht ad Leiden Universities [143].”
BackgroundResultInfluentialKerkhofs, D., Wong, S. M., Zhang, E., Staals, J., Jansen, J. F. A., van Oostenbrugge, R. J., & Backes, W. H. (2021) · Neurology · doi:10.1212/wnl.0000000000011783 · Cited by 79
Self-citationParodi-Rullán, R. M., Javadov, S., & Fossati, S. (2021) · Cells · doi:10.3390/cells10112903 · Cited by 73
Advanced Neuroimaging of Cerebral Small Vessel Disease
Blair, G. W., Hernandez, M. V., Thrippleton, M. J., Doubal, F. N., & Wardlaw, J. M. (2017) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-017-0555-1 · Cited by 70
Basal lamina changes in neurodegenerative disorders
Nguyen, B., Bix, G., & Yao, Y. (2021) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00502-y · Cited by 75
The leukotriene signaling pathway: a druggable target in Alzheimer’s disease
Michael, J., Marschallinger, J., & Aigner, L. (2018) · Drug Discovery Today · doi:10.1016/j.drudis.2018.09.008 · Cited by 75
Carter, C. J. (2017) · Journal of Alzheimer's Disease Reports · doi:10.3233/adr-170017 · Cited by 69
Endothelial Nitric Oxide Synthase–Deficient Mice
Liao, F., Lin, G., Chen, X., Chen, L., Zheng, W., Raghow, R., Zhou, F.-M., Shih, A. Y., & Tan, X.-L. (2021) · American Journal Of Pathology · doi:10.1016/j.ajpath.2021.02.022 · Cited by 74
Sex-Related Differences in Regional Blood–Brain Barrier Integrity in Non-Demented Elderly Subjects
Moon, Y., Lim, C., Kim, Y., & Moon, W. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22062860 · Cited by 74
Gut microbiota in dementia. Critical review of novel findings and their potential application
Łuc, M., Misiak, B., Pawłowski, M., Stańczykiewicz, B., Zabłocka, A., Szcześniak, D. M., Pałęga, A., & Rymaszewska, J. (2020) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.110039 · Cited by 74
Piccialli, I., Tedeschi, V., Caputo, L., D’Errico, S., Ciccone, R., De Feo, V., Secondo, A., & Pannaccione, A. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.876614 · Cited by 73
Water-exchange MRI detects subtle blood-brain barrier breakdown in Alzheimer's disease rats
Dickie, B., Vandesquille, M., Ulloa, J. L., Boutin, H., Parkes, L. M., & Parker, G. J. M. (2018) · NeuroImage · doi:10.1016/j.neuroimage.2018.09.030 · Cited by 73
Moon, W.-J., Lim, C., Ha, I. H., Kim, Y., Moon, Y., Kim, H.-J., & Han, S.-H. (2021) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x20952012 · Cited by 66
Shi, H., Koronyo, Y., Fuchs, D.-T. S., Sheyn, J., Wawrowsky, K., Lahiri, S., Black, K. L., & Koronyo‐Hamaoui, M. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-01076-4 · Cited by 72
Faridar, A., Vasquez, M., Thome, A. D., Yin, Z., Xuan, H., Wang, J. H., Wen, S., Li, X., Thonhoff, J. R., Zhao, W., et al. (2022) · Acta Neuropathologica Communications · doi:10.1186/s40478-022-01447-z · Cited by 71
Complement-mediated synapse loss in Alzheimer’s disease: mechanisms and involvement of risk factors
Wen, L., Bi, D., & Shen, Y. (2023) · Trends in Neurosciences · doi:10.1016/j.tins.2023.11.010 · Cited by 71
A Leaky Blood–Brain Barrier to Fibrinogen Contributes to Oxidative Damage in Alzheimer’s Disease
McLarnon, J. G. (2021) · Antioxidants · doi:10.3390/antiox11010102 · Cited by 69
Quarles, C. C., Bell, L. C., & Stokes, A. M. (2018) · NeuroImage · doi:10.1016/j.neuroimage.2018.04.069 · Cited by 70
“(2016) utilized a dual-time resolution DCE-MRI consisting of fast and slow pulse sequences to characterize both initial vascular arrival and slower CA tissue extravasation / wash-out, respectively (Haar et al., 2016).”
New Insight Into the Pathogenesis of Cerebral Small-Vessel Diseases
Müller, K., Courtois, G., Ursini, M. V., & Schwaninger, M. (2017) · Stroke · doi:10.1161/strokeaha.116.012888 · Cited by 68
Alzheimer's disease: Innate immunity gone awry?
VanItallie, T. B. (2017) · Metabolism · doi:10.1016/j.metabol.2017.01.014 · Cited by 67
Kerkhofs, D., Wong, S. M., Zhang, E., Uiterwijk, R., Hoff, E. I., Jansen, J. F. A., Staals, J., Backes, W. H., & van Oostenbrugge, R. J. (2021) · GeroScience · doi:10.1007/s11357-021-00399-x · Cited by 66
Self-citationInnate Immunity Cells and the Neurovascular Unit
Presta, I., Vismara, M. F. M., Novellino, F., Donato, A., Zaffino, P., Scali, E., Pirrone, K. C., Spadea, M. F., Malara, N., & Donato, G. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19123856 · Cited by 67
Iron and Alzheimer’s Disease: From Pathology to Imaging
Tran, D. Q., DiGiacomo, P., Born, D. E., Georgiadis, M., & Zeineh, M. (2022) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2022.838692 · Cited by 65
Voorter, P., van Dinther, M., Jansen, W. J., Postma, A. A., Staals, J., Jansen, J. F. A., van Oostenbrugge, R. J., van der Thiel, M. M., & Backes, W. H. (2023) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.28989 · Cited by 65
Self-citationA Comprehensive View on MRI Techniques for Imaging Blood-Brain Barrier Integrity
Elschot, E. P., Backes, W. H., Postma, A. A., van Oostenbrugge, R. J., Staals, J., Rouhl, R. P. W., & Jansen, J. F. A. (2020) · Investigative Radiology · doi:10.1097/rli.0000000000000723 · Cited by 64
Self-citationMontagne, A., Barnes, S. R., Nation, D. A., Kisler, K., Toga, A. W., & Zloković, B. V. (2022) · GeroScience · doi:10.1007/s11357-022-00571-x · Cited by 63
Gomes, P., Tzouanou, F., Skolariki, K., Vamvaka-Iakovou, A., Noguera-Ortiz, C., Tsirtsaki, K., Waites, C. L., Vlamos, P., Sousa, N., Costa-Silva, B., et al. (2022) · Experimental Neurology · doi:10.1016/j.expneurol.2022.114183 · Cited by 55
Liu, S., Gao, J., Liu, K., & Zhang, H. (2021) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111560 · Cited by 61
van Osch, M. J. P., Wåhlin, A., Scheyhing, P., Mossige, I., Hirschler, L., Eklund, A., Mogensen, K., Gomolka, R. S., Radbruch, A., Qvarlander, S., et al. (2024) · NMR in Biomedicine · doi:10.1002/nbm.5159 · Cited by 61
Pardridge, W. M. (2016) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2016.1230195 · Cited by 56
Borsom, E. M., Lee, K., & Cope, E. K. (2020) · Brain Sciences · doi:10.3390/brainsci10110814 · Cited by 61
Claudin-5: A Pharmacological Target to Modify the Permeability of the Blood–Brain Barrier
Hashimoto, Y., Campbell, M., Tachibana, K., Okada, Y., & Kondoh, M. (2021) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b21-00408 · Cited by 59
Sekhar, G. N., Fleckney, A. L., Boyanova, S., Rupawala, H., Lo, R., Wang, H., Farag, D. B., Rahman, K. M., Broadstock, M., Reeves, S., et al. (2019) · Fluids and Barriers of the CNS · doi:10.1186/s12987-019-0158-1 · Cited by 59
Yan, Z., Zhou, Z., Wu, Q., Chen, Z. B., Koo, E. H., & Zhong, S. (2020) · Current Biology · doi:10.1016/j.cub.2020.02.084 · Cited by 58
“The BBB leakiness in early AD likely makes it more permissive to the passage of all types of extracellular molecules [60, 61].”
Ji, F., Pasternak, O., Ng, K. K., Chong, J. S. X., Liu, S., Zhang, L., Shim, H. Y., Loke, Y. M., Tan, B. Y., Venketasubramanian, N., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-41363-2 · Cited by 58
Blood-brain barrier integrity is the primary target of alcohol abuse
Wei, J., Dai, Y., Wen, W., Li, J., Ye, L. L., Xu, S., & Duan, D. D. (2021) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2021.109400 · Cited by 58
Dementia in Diabetes: The Role of Hypoglycemia
Husain, K. H., Sarhan, S. F., AlKhalifa, H. K. A. A., Buhasan, A., Moin, A. S. M., & Butler, A. E. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24129846 · Cited by 58
Quantitative Water Permeability Mapping of Blood-Brain-Barrier Dysfunction in Aging
Ford, J. N., Zhang, Q., Sweeney, E. M., Merkler, A. E., de Leon, M. J., Gupta, A. K., Nguyen, T. D., & Ivanidze, J. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.867452 · Cited by 57
Chang, R., Maghribi, A. A., Vanderpoel, V., Vasilevko, V., Cribbs, D. H., Boado, R. J., Pardridge, W. M., & Sumbria, R. K. (2018) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.8b00594 · Cited by 57
Necroptosis and Alzheimer’s Disease: Pathogenic Mechanisms and Therapeutic Opportunities
Zhang, R., Song, Y., & Su, X. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220809 · Cited by 56
Early-Life Lead Exposure: Risks and Neurotoxic Consequences
Bjørklund, G., Tippairote, T., Hangan, T., Chirumbolo, S., & Peana, M. (2023) · Current Medicinal Chemistry · doi:10.2174/0929867330666230409135310 · Cited by 56
Quantitative PET imaging and modeling of molecular blood-brain barrier permeability
Chung, K. J., Abdelhafez, Y. G., Spencer, B. A., Jones, T., Quyen, T. N. T., Nardo, L., Chen, M. S., Sarkar, S., Medici, V., Lyo, V., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-58356-7 · Cited by 56
Physiological and Pathological Ageing of Astrocytes in the Human Brain
Verkerke, M., Hol, E. M., & Middeldorp, J. (2021) · Neurochemical Research · doi:10.1007/s11064-021-03256-7 · Cited by 47
Chen, Q., Cao, T., Li, N., Zeng, C., Zhang, S., Wu, X., Zhang, B., & Cai, H. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.667874 · Cited by 57
Biomarkers Assessing Endothelial Dysfunction in Alzheimer’s Disease
Custodia, A., Aramburu-Núñez, M., Rodríguez-Arrizabalaga, M., Pías-Peleteiro, J. M., Vázquez-Vázquez, L., Camino-Castiñeiras, J., Aldrey, J. M., Castillo, J., Ouro, A., Sobrino, T., et al. (2023) · Cells · doi:10.3390/cells12060962 · Cited by 44
High‐fat diet protects the blood–brain barrier in an Alzheimer's disease mouse model
Elhaik Goldman, S., Goez, D., Last, D., Naor, S., Liraz Zaltsman, S., Sharvit‐Ginon, I., Atrakchi‐Baranes, D., Shemesh, C., Twitto‐Greenberg, R., Tsach, S., et al. (2018) · Aging Cell · doi:10.1111/acel.12818 · Cited by 51
The Glymphatic System in Diabetes-Induced Dementia
Kim, Y., Nam, K. I., & Song, J. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00867 · Cited by 55
“The increased permeability of the BBB triggers glymphatic pathway impairment and ultimately leads to the defective clearance of Aβ by BBB transport in dementia (42, 57).”
BackgroundEfflux proteins at the blood–brain barrier: review and bioinformatics analysis
Saidijam, M., Dermani, F. K., Sohrabi, S., & Patching, S. G. (2017) · Xenobiotica · doi:10.1080/00498254.2017.1328148 · Cited by 54
“…blood–brain barrier has also been demonstrated in early Alzheimer’s disease, multiple sclerosis, Parkinson’s disease and as a result of HIV and viral protein-mediated injury (Desai et al., 2007; Gray & Woulfe, 2015; Lund et al., 2013; McRae, 2016; Shawahna, 2015; van de Haar et al., 2016).”
Background
Metadata
- Authors
- van de Haar, H. J., Burgmans, S., Jansen, J. F. A., van Osch, M. J. P., van Buchem, M. A., Muller, M., Hofman, P. A. M., Verhey, F. R. J., & Backes, W. H.
- Affiliations
- Maastricht University Medical Centre (NL)
- Leiden University Medical Center (NL)
- Leiden University (NL)
- ORCID
- Venue
- Radiology
- Published
- 2016-11
- Volume
- 281
- Issue
- 2
- Pages
- 527-535
- ISSN
- 0033-8419 (ISSN-L)
- 1527-1315
- OpenAlex
- W2415637550
- Cited by
- 601
- References
- 32
- Citations by year
- 2026: 37 · 2025: 56 · 2024: 66 · 2023: 65 · 2022: 81 · 2021: 89 · 2020: 64 · 2019: 50 · 2018: 42 · 2017: 36 · 2016: 13
- FWCI
- 25.63
- Type
- journal article
- Language
- en
- Open access
- Licence
- other-oa
- Locations
- Radiology (publishedVersion)
- PubMed (publishedVersion)
- Research Publications (Maastricht University) (publishedVersion, other-oa)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
- Pure Amsterdam UMC (acceptedVersion, other-oa)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Leiden Repository (Leiden University) (submittedVersion)
- Research Publications (Maastricht University) (submittedVersion, other-oa)
- Funders
- Radiological Society of North America
- Internationale Stichting Alzheimer Onderzoek (10553)
- Topics
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- blood-brain barrier disruption, early Alzheimer's disease, dynamic contrast-enhanced MRI, Patlak graphical analysis, plasma volume, gray matter, normal-appearing white matter, deep gray matter, cognitive decline, Mini-Mental State Examination
- MeSH terms
- Aged, Aged, 80 and over, Alzheimer Disease, Blood Volume, Blood-Brain Barrier, Contrast Media, Female, Humans, Magnetic Resonance Imaging, Male, Middle Aged, Pilot Projects, Case-Control Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.